1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6823D22AAB5B85D950025857A0024C931
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/effective-practices-speaker-programs-physician-advisory-boards-during-covid-19-pandemic?OpenDocument
18
19OpenDocument
2044.192.95.161
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Marketing Management » Marketing Strategy

Effective Practices for Speaker Programs and Physician Advisory Boards during and after the COVID-19 Pandemic

ID: CM-7


Features:

7 Info Graphics

9 Data Graphics

75+ Metrics

7 Narratives


Pages: 24


Published: 2020


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
The pharmaceutical industry gains strategic inputs from physician advisory boards to deliver high quality patient care, and relies on speaker programs to educate the medical community about disease states and the new products it brings to market to treat them.

The COVID-19 pandemic has disrupted the administration of these critical programs, driving many drug manufacturers to adopt virtual and other innovative approaches to accomplish them.

Best Practices, LLC conducted this benchmarking research to identify effective practices for managing virtual speaker programs and physician advisory boards during the COVID-19 pandemic, and to explore innovative approaches that will drive success in the future.

This report examines key challenges related to virtual speaker programs, approaches to addressing virtual program challenges, speaker program training formats for new and existing products, tactics to enhance virtual physician advisory boards, and managing virtual dinner programs and training during and post-COVID-19.

Industries Profiled:
Medical Device; Biotech; Health Care; Pharmaceutical; Consulting; Biopharmaceutical; Communications; Professional Services


Companies Profiled:
Alcon; Allergan; Avant Healthcare; B. Braun; Boehringer Ingelheim; Cofactor Group; Ethypharm; IDbyDNA; Merck; Merck Sharp & Dohme; Paratek Pharmaceuticals; Prime Global; Roche; Straumann; Takeda Pharmaceuticals; Wellspect HealthCare

Study Snapshot

Best Practices, LLC engaged 17 leaders from 16 life sciences organizations in this research through a benchmarking survey. Nearly 60% of the participants serve at the Director / Head level or above.

Key topics covered in this report include:

  • Managing Virtual Speaker Programs
  • Speaker Program Training
  • Physician Advisory Boards


Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Effectiveness of Virtual Speaker Programs: Quality content that stimulates and engages participants seen as best way to improve effectiveness and attendance of virtual speaker programs. Getting renowned speakers and providing real-time technical assistance also seen as effective ways to address challenges of virtual programs.
  • Physician ad boards will make a significant shift to the virtual format post COVID-19: While 90% of participants’ physician ad boards were in the face-to-face format in 2019, that practice will fall to 54% post COVID-19. Meanwhile, the virtual format will increase from 10% in 2019 to 46% post COVID-19.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Overviewpgs. 3-7
Universe of Learningpg. 4
Key Findingspgs. 5-6
Key Actionspg. 7
II.
Managing Virtual Speaker Programspgs. 8-13
III.
Speaker Program Trainingpgs. 14-16
IV.
Physician Advisory Boardspgs. 17-21
V.
Participant Demographicspgs. 22-23
VI.
About Best Practices, LLCpg. 24

    List of Charts & Exhibits

    I. Managing Virtual Speaker Programs

    • Key challenges with virtual speaker programs
    • Effectively addressing key challenges with virtual programs
    • Participant approaches to addressing virtual program challenges
    • Most effective actions being used to enhance the effectiveness of virtual speaker programs
    • Percentage of speaker programs were/are being done live (face to face), virtual, and taped for on-demand – Before, during, and post COVID-19

    II. Speaker Program Training

    • Speaker program training formats for new products – Before, during, and post COVID-19
    • Speaker program training formats for existing products – Before, during, and post COVID-19

    III. Physician Advisory Boards

    • Format utilization for physician advisory boards – Before, during, and post COVID-19
    • Most effective tools for enhancing virtual physician advisory boards
    • Key roles/functions for future success in utilizing virtual speaker programs and physician advisory boards
    • Executive narrative around managing virtual dinner programs and training during COVID-19